The Company was founded by Louis Plante, a cystic fibrosis (CF) patient, and Yvon Robert, with the sole purpose of improving the quality and care of those struggling to breathe due to mucus filled lungs.
In 2006, following four years of research and in collaboration with a medical team from Sherbrooke University in Quebec, Canada, Dymedso launched the first version of its digitally-controlled acoustic airway clearance device, the Frequencer® 1001. In 2010, Dymedso launched the latest version of the Frequencer® used by hundreds of patients and hospitals around the world today.